- Title: Subtitle
- Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes Analysis
- Creators
- C.A. Rountree - Medical University of South CarolinaA. Zahra - University of Iowa Hospitals and ClinicsJ.K. Russo - Bismarck Cancer Center Department of Radiation Oncology, Bismarck, NDJ. O'Keefe - University of North DakotaN.S. Andresen - University of IowaS.L. Mott - University of IowaD. Herr - Medical University of South CarolinaB.G. Allen - University of IowaA.K. Sharma - Medical University of South CarolinaS.K. Bhatia - University of IowaJ. Buatti - University of IowaJ.M. Watkins - University of Iowa
- Resource Type
- Abstract
- Publication Details
- International journal of radiation oncology, biology, physics, Vol.98(1), pp.243-244
- DOI
- 10.1016/j.ijrobp.2017.01.180
- PMID
- 28587025
- NLM abbreviation
- Int J Radiat Oncol Biol Phys
- ISSN
- 0360-3016
- eISSN
- 1879-355X
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 05/01/2017
- Academic Unit
- Radiation Oncology; Writers’ Workshop; Neurosurgery; Otolaryngology
- Record Identifier
- 9984304997102771
Abstract
Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes Analysis
International journal of radiation oncology, biology, physics, Vol.98(1), pp.243-244
05/01/2017
DOI: 10.1016/j.ijrobp.2017.01.180
PMID: 28587025
Details
Metrics
33 Record Views